Cancer Database Query Results

Scientific Papers found: Click to Expand⟱
8304- FS,    Flaxseed-derived enterolactone is inversely associated with tumor cell proliferation in men with localized prostate cancer
- Trial, Pca, NA
NF-kB↓, VEGF↓, Ki-67↓, TumCP↓,
8587- FS,  Rad,    Phase II Trial of Flaxseed to Prevent Acute Complications After Chemoradiation for Lung Cancer
- Trial, Lung, NA
*Dose↝, *eff↝,
8604- FSO,  VitD3,    An 8-Week Triple-Blind, Randomized, Placebo-Controlled Trial Evaluating High-Dose Vitamin D3 and Flaxseed Oil for Inflammation and Metabolic Health in Elderly Patients With Type 2 Diabetes: Implications for Clinical Management
- Trial, Diabetic, NA
*TAC↑, *Weight↓, *glucose↓, *Insulin↓, *TG/TAG↓, *TC↓, *QoL↑, *Pain↓, *toxicity↓, *Dose↝,
8603- FSO,    Flaxseed oil supplementation decreases C-reactive protein levels in chronic hemodialysis patients
- Trial, Nor, NA
*Dose↝, *CRP↓,
8602- FSO,    Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults
- Trial, AD, NA
*Dose?, Verbal↑,
7015- Fuc,    Effects of Ingesting Fucoidan Derived from Cladosiphon okamuranus Tokida on Human NK Cells: A Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Pilot Study
- Trial, Nor, NA
*NK cell↑, *toxicity↓,
7018- Fuc,    Absorption Study of Mozuku Fucoidan in Japanese Volunteers
- Trial, Nor, NA
*Dose↝, *BioAv↝, *eff↝, *Inflam↓, *AntiThr↑, angioG↓, *AntiViral↑, *AntiTum↑, *antiOx↓, *BioAv↝,
7023- Fuc,    The Use of Oligo Fucoidan in Cancer Bearing Dogs Undergoing Chemotherapy: A Double-Blinded Study
- Trial, Var, NA
QoL∅, QoL↑,
7001- Fuc,    Fucoidan reduces the toxicities of chemotherapy for patients with unresectable advanced or recurrent colorectal cancer
- Trial, CRC, NA
fatigue↓, Synergy↑, OS↑,
7000- Fuc,    Efficacy of Low-Molecular-Weight Fucoidan as a Supplemental Therapy in Metastatic Colorectal Cancer Patients: A Double-Blind Randomized Controlled Trial
- Trial, CRC, NA
DCR↑, OS∅, PFS∅, ORR∅, AEs∅, QoL∅,
6999- Fuc,    Fucoidan Improves Tumour Control and Liver Function in TACE for Unresectable Hepatocellular Carcinoma: A Randomised Trial
- Trial, HCC, NA
hepatoP↑, toxicity↓,
7002- Fuc,    The Auxiliary Effects of Low-Molecular-Weight Fucoidan in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy Before Surgery: A Double-Blind, Randomized, Placebo-Controlled Study
- Trial, CRC, NA
fatigue↓, GutMicro↑,
7003- Fuc,  Chemo,    An Exploratory Study on the Anti-inflammatory Effects of Fucoidan in Relation to Quality of Life in Advanced Cancer Patients
- Trial, Var, NA
IL1β↓, TNF-α↓, Inflam↓,
7040- GA,    Effects of gallic acid on acrylamide-induced endoplasmic reticulum stress, neuroinflammation and neuronal apoptosis in rats
- Trial, AD, NA
*SOD↑, *GSH↑, *GPx↑, *Catalase↑, *MDA↓, *TNF-α↓, *IL1β↓, *BAX↓, *Casp3↓, *BDNF↑, *NRF2↑, *HO-1↑,
7072- GABA,  CHOC,    Psychological stress-reducing effect of chocolate enriched with gamma-aminobutyric acid (GABA) in humans: assessment of stress using heart rate variability and salivary chromogranin A
- Trial, Nor, NA
*Dose↝, *Stress↓,
7071- GABA,    Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks
- Trial, Nor, NA
*memory↑, *BP↓, *Dose↝, *Stress↓,
7075- GABA,    Effects of γ-aminobutyric acid supplementation on glucose control in adults with prediabetes: A double-blind, randomized, placebo-controlled trial
- Trial, Diabetic, NA
*Dose↝, *glucose∅,
7074- GABA,    Effect of oral γ-aminobutyric acid (GABA) administration on sleep and its absorption in humans
- Trial, Nor, NA
*Sleep↑,
7076- GABA,    Anti-hypertensive effect of gamma-aminobutyric acid (GABA)-rich Chlorella on high-normal blood pressure and borderline hypertension in placebo-controlled double blind study
- Trial, Nor, NA
*Dose↝, *BP↓, *eff↑,
7077- GABA,    GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial
- Trial, Nor, NA
*Sleep↑, *Dose↝, *other↝,
7073- GABA,    Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial
- Trial, Nor, NA
*Sleep↑,
7061- GamB,    An open-labeled, randomized, multicentered, phase IIa study for advanced cancer treatment by gambogic acid injection (THS)
- Trial, Var, NA
ORR↑, DCR↑, *toxicity↓,
7054- GamB,    An open-labeled, randomized, multicenter phase IIa study of gambogic acid injection for advanced malignant tumors
- Trial, Var, NA
Dose↝, DCR↝,
7189- GBE,    Clinical and genomic safety of treatment with Ginkgo biloba L. leaf extract (IDN 5933/Ginkgoselect®Plus) in elderly: a randomised placebo-controlled clinical trial [GiBiEx]
- Trial, Nor, NA
*Dose↝, *toxicity↓,
7188- GBE,    Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trial
- Trial, AD, NA
*Dose↝, *cognitive↑,
7187- GBE,    Ginkgo biloba for prevention of dementia: a randomized controlled trial
- Trial, AD, NA
*Dose↝, Risk∅, eff∅,
7670- GCL2505,    Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial
- Trial, AD, NA
*cognitive↑, *GutMicro↑, *Inflam↓, *Dose↝, *BDNF∅,
7130- Ge-132,    Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer
- Trial, BC, NA
IL6↓, TumMeta↓, Dose↝, MCP1/CCL2↓,
7128- Ge-132,    Pharmacokinetics of germanium after po beta-carboxyethylgermanium sesquioxide in 24 Chinese volunteers
- Trial, Nor, NA
*Half-Life↝,
7126- Ge-132,    Immune activation of Bio-Germanium in a randomized, double-blind, placebo-controlled clinical trial with 130 human subjects: Therapeutic opportunities from new insights
- Trial, Nor, NA
AntiTum↑, AntiCan↑, *AntiAge↑, *AntiViral↑, *Inflam↓, *NK cell↑, *Imm↑, *TNF-α↑,
7107- GEN,    Inhibition of prostaglandin synthesis and actions by genistein in human prostate cancer cells and by soy isoflavones in prostate cancer patients
- Trial, Pca, NA - in-vitro, Pca, LNCaP - in-vitro, Pca, PC3
COX2/PTGS2↓, P21↑, PGE2↓, other↑, Dose↝,
7109- GEN,    Single- and multiple-dose pharmacokinetics of genistein capsules in healthy chinese subjects: A phase I, randomized, open-label study
- Trial, Nor, NA
*Dose↝, *BioAv↝, *BioAv↝, *BioAv↝,
7106- GEN,  VitD3,    Phase IIa, randomized placebo-controlled trial of single high dose cholecalciferol (vitamin D3) and daily Genistein (G-2535) versus double placebo in men with early stage prostate cancer undergoing prostatectomy
- Trial, Pca, NA
Dose↝, toxicity↓, VitD↑, AR↝,
7105- GEN,    Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer
- Trial, Pca, NA
Risk↓, Myc↓, PTEN↑, Dose↝, NOTCH3↑, JAG1↑, ADCY4↑, NEU1↑,
7104- GEN,    Efficacy and safety of short-term genistein intervention in patients with localized prostate cancer prior to radical prostatectomy: a randomized, placebo-controlled, double-blind Phase 2 clinical trial
- Trial, Pca, NA
Dose↝, PSA↓, *LDL↓,
7115- GeS,    A phase II study of spirogermanium as second line therapy in patients with poor prognosis lymphoma. An NCI Canada Clinical Trials Group Study
- Trial, lymphoma, NA
eff↓, toxicity↝,
7142- GI,    Phase II study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer
- Trial, Nor, NA
COX2/PTGS2↓, *PGE2↓, *5-HETE↓, *12-HETE↓, *Eic↓, *AntiCan↑, *antiOx↑, *Inflam↓, 5LO↓, eff↝,
7143- GI,  Chemo,    Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial
- Trial, Var, NA
Dose↝, chemoPv↑, Nausea↓, Vomit↓, mal↓, QoL↑,
7144- GI,  Cisplatin,    A randomized, double-blind, placebo-controlled, multicenter study of a ginger extract in the management of chemotherapy-induced nausea and vomiting (CINV) in patients receiving high-dose cisplatin
- Trial, Var, NA
Dose↝, Nausea∅, Vomit∅,
7145- GI,  Chemo,    Efficacy of ginger for prophylaxis of chemotherapy-induced nausea and vomiting in breast cancer patients receiving adriamycin-cyclophosphamide regimen: a randomized, double-blind, placebo-controlled, crossover study
- Trial, BC, NA
Dose↝, toxicity∅, Nausea∅, Vomit∅,
7135- GI,    Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans
- Trial, Nor, NA
*Dose↝, *Half-Life↝, *antiOx↑, *Inflam↓, *AntiTum↑, *Half-Life↓,
7152- GI,    Role of Ginger in management of nausea among patients receiving chemotherapy
- Trial, Var, NA
Dose↝, Nausea↓, Vomit↓,
7155- GI,  BSB,    Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer
- Trial, BC, NA
Dose↝, Dose↝, Vomit↓, Nausea↓, *toxicity↓,
7158- GI,    Ginger-partitioned moxibustion in the prevention of nausea and vomiting induced by chemotherapy in lung cancer:a randomized controlled trial
- Trial, Lung, NA
Vomit↓, Nausea↓, toxicity↓, other↝,
2465- GI,    Effect of daily ginger consumption on platelet aggregation
- Trial, Nor, NA
AntiAg↝, Dose∅,
7295- Gins,    Effect of Korean Red Ginseng on Cognitive Function and Quantitative EEG in Patients with Alzheimer's Disease: A Preliminary Study
- Trial, AD, NA
*cognitive↑,
7280- Gins,    Pharmacokinetics of ginsenoside Rb1 and its metabolite compound K after oral administration of Korean Red Ginseng extract
- Trial, Nor, NA
*BioAv↑, *Half-Life↝, *eff↝,
3998- Gins,    Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Trial, AD, NA
*other↝,
4002- Gins,    Improvement of cognitive deficit in Alzheimer's disease patients by long term treatment with korean red ginseng
- Trial, AD, NA
*cognitive↑, *other↑,
3999- Gins,    Panax ginseng enhances cognitive performance in Alzheimer disease
- Trial, AD, NA
*cognitive↑,

Showing Research Papers: 201 to 250 of 542
Prev Page 5 of 11 Next

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 542

Pathway results for Effect on Cancer / Diseased Cells:


NA, unassigned(tgid=0) ⓘ

NA↑, 2,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↑, 2,   Bil∅, 1,   Copper↓, 2,   CoQ10↑, 1,   GSH↓, 1,   MDA↓, 1,   ROS↓, 3,   ROS↑, 5,   ROS↝, 2,   SOD↑, 1,   TrxR↓, 1,   VitC↑, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

selm↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

BCR-ABL↓, 1,   Insulin↓, 2,   PGC-1α↑, 2,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

5LO↓, 1,   ALAT↓, 1,   FAO↑, 1,   lactateProd↓, 1,   PDK1 / PDPK1↓, 2,  

Cell Death(tgid=5) ⓘ

Apoptosis↑, 8,   Bcl-2↓, 3,   Bcl-xL↓, 2,   Cyt‑c↝, 1,   IAP1↓, 1,   Mcl-1↓, 3,   NOXA↑, 1,   Perforin↑, 1,   PUMA↑, 1,   survivin↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

ADCY4↑, 1,   p‑Akt↓, 1,   EGFR↓, 3,   IGF-2R↑, 1,   IGFR↓, 1,   PI3K↓, 1,   PTEN↑, 2,  

Transcription & Epigenetics(tgid=7) ⓘ

HDAC↓, 4,   miR-106b↓, 1,   miR-19b↓, 1,   miR-29b↑, 1,   miR-30a-5p↑, 1,   Myc↓, 1,   other?, 1,   other↓, 4,   other↑, 6,   other↝, 24,   other∅, 3,   SD↑, 5,   SD↝, 1,  

Autophagy & Lysosomes(tgid=9) ⓘ

NEU1↑, 1,   TumAuto↓, 1,   TumAuto↑, 1,  

DNA Damage & Repair(tgid=10) ⓘ

8-oxo-dG↓, 1,   NKX3.1↓, 1,   P53↑, 1,   RAD51↓, 1,  

Cell Cycle & Senescence(tgid=11) ⓘ

cellSen?, 1,   cycD1/CCND1↓, 2,   Ki-67↓, 6,   P21↑, 3,   TumCCA↑, 5,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

ALDH↓, 1,   CSCs↓, 2,   HH↓, 3,   HH∅, 1,   IGF-1↓, 7,   IGF-1↑, 1,   IGFBP1↑, 2,   IGFBP3↓, 1,   IGFBP3↑, 1,   JAG1↑, 1,   Ki-67↓, 6,   NOTCH3↑, 1,   Smo↓, 1,   TumCG↓, 9,   TumCP↓, 11,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↝, 1,   AntiAg∅, 1,   Ca+2↓, 1,   Ca+2↑, 1,   GLI3↓, 1,   MMP2↓, 1,   MMP9↓, 2,   MMP9:TIMP1↑, 1,   Slug↓, 2,   p‑SMAD2↓, 1,   p‑SMAD3↓, 1,   Snail↓, 1,   TGF-β↓, 1,   TIMP1↓, 1,   TumCA↓, 3,   TumCI↓, 3,   TumCMig↓, 3,   TumMeta↓, 2,   TumMeta↑, 1,   TumMeta∅, 1,   Twist↓, 1,   Vim↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14) ⓘ

angioG↓, 9,   angioG∅, 1,   E-sel↓, 1,   Endoglin↓, 1,   Hif1a↓, 2,   PGI2↓, 1,   VEGF↓, 4,   VEGFR2/KDR/Flk1↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,   MPT↑, 1,   TRPV1↑, 1,   ZO-1↓, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

ALC↓, 1,   ANXA1↓, 1,   CD14↓, 1,   CD25+↓, 1,   CD4+↓, 1,   CD4+↑, 3,   CD8+↑, 5,   COX2/PTGS2↓, 4,   COX2/PTGS2∅, 1,   Eos↑, 1,   FoxP3+↓, 1,   Gal-3?, 1,   Gal-3↓, 1,   GM-CSF↓, 1,   IFN-γ↑, 2,   IL10↓, 1,   IL10↑, 1,   IL12↓, 1,   IL18↑, 1,   IL1β↓, 2,   IL1β∅, 1,   IL2↑, 1,   IL22↓, 1,   IL6↓, 4,   Imm↑, 12,   Imm⇅, 1,   Imm↝, 1,   INF-γ↝, 1,   Inflam↓, 9,   LIF↑, 1,   MCP1/CCL2↓, 1,   Neut↓, 1,   Neut↑, 2,   NF-kB↓, 4,   NK cell↑, 4,   PDT+↓, 1,   PGE2↓, 2,   PSA↓, 16,   T-Cell↑, 1,   TNF-α↓, 2,   TNF-α↑, 1,   TNF-α∅, 1,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

BDNF↓, 1,   TrkB↓, 1,  

Protein Aggregation(tgid=19) ⓘ

AGEs↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↓, 1,   2/16-OHE1↑, 1,   2/16-OHE1↝, 1,   ADRB2↓, 1,   AR↓, 3,   AR↝, 1,   DHT↓, 1,   ENL↑, 1,   EstroRS/ERS↑, 1,   PPARγ↓, 1,   SHBG↑, 1,   testos↓, 1,   testos∅, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 2,   BioAv↑, 10,   BioAv↝, 10,   BioEnh↑, 1,   ChemoSen↑, 8,   ChemoSen∅, 1,   CYP1A2↑, 1,   CYP3A4⇅, 1,   Dose?, 13,   Dose↓, 3,   Dose↑, 7,   Dose↝, 152,   Dose∅, 4,   eff↓, 3,   eff↑, 40,   eff↝, 8,   eff∅, 12,   Half-Life↑, 1,   Half-Life↝, 6,   P-gp/ABCB1↓, 2,   RadioS↑, 5,   selectivity↑, 5,   Synergy?, 1,   Synergy↑, 10,   Synergy∅, 1,   TET2↑, 1,  

Clinical Biomarkers(tgid=22) ⓘ

ALAT↓, 1,   ALB∅, 1,   AR↓, 3,   AR↝, 1,   AST↓, 1,   BG↓, 1,   Bil∅, 1,   BUN↓, 1,   CA125↓, 1,   CA125∅, 1,   CA19-9↓, 1,   CEC↝, 1,   CIT↓, 1,   creat↓, 1,   CRP↓, 3,   CRP∅, 1,   CTC↓, 1,   EGFR↓, 3,   EstroRS/ERS↑, 1,   HemoG↑, 1,   IL6↓, 4,   Myc↓, 1,   Mye↓, 1,   NLR↓, 1,   PC↑, 3,   Polyps↓, 1,   PSA↓, 16,   PSADT↓, 1,   PSADT↑, 3,   RBC↑, 4,   UFR↑, 1,   Verbal↑, 2,   VitD↑, 1,   WBC↑, 2,  

Functional Outcomes(tgid=23) ⓘ

AEs∅, 1,   AntiCan↓, 1,   AntiCan↑, 6,   antiD↑, 4,   antiNeop↑, 2,   AntiTum↑, 4,   AntiTum∅, 1,   ANXi↓, 4,   APG↓, 2,   cachexia↓, 1,   cardioP↑, 4,   CardioT↑, 1,   CardioT↝, 1,   chemoP↑, 8,   chemoP∅, 1,   chemoPv↑, 5,   ChemoSideEff↓, 2,   cognitive↑, 1,   cognitive∅, 1,   CR↑, 5,   DCR↑, 5,   DCR↝, 1,   fatigue↓, 5,   fatigue∅, 1,   hepatoP↓, 1,   hepatoP↑, 2,   LC↑, 1,   mal↓, 1,   memory↑, 2,   Mood↑, 1,   Mucositis↓, 5,   Nausea↓, 4,   Nausea∅, 2,   neuroP↑, 1,   NP/CIPN↓, 2,   NP/CIPN↑, 3,   Obesity↓, 1,   ORR↑, 4,   ORR∅, 1,   OS?, 1,   OS↑, 55,   OS↝, 1,   OS∅, 11,   Pain↓, 9,   PFS?, 1,   PFS↑, 9,   PFS∅, 1,   QoL↑, 21,   QoL↝, 1,   QoL∅, 4,   radioP?, 1,   radioP↑, 5,   radioP↝, 1,   Remission↑, 3,   RFS↑, 1,   Risk↓, 14,   Risk↑, 2,   Risk↝, 2,   Risk∅, 6,   stomatitis↓, 1,   Strength↑, 1,   Strength∅, 1,   Stress↓, 1,   toxicity↓, 29,   toxicity↑, 1,   toxicity↝, 26,   toxicity∅, 1,   TTP↑, 1,   TumVol↓, 4,   TumW↓, 1,   Vomit↓, 4,   Vomit∅, 2,   Weight↑, 6,   Weight∅, 2,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

Diar↓, 1,   Diar⇅, 1,   GutMicro↑, 3,   Inf↓, 4,   Sepsis↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↑, 1,   Ingr↝, 4,  
Total Targets: 317

Pathway results for Effect on Normal Cells:


NA, unassigned(tgid=0) ⓘ

NA↓, 1,   NA↑, 1,   NA↝, 1,  

Redox & Oxidative Stress(tgid=1) ⓘ

antiOx↓, 2,   antiOx↑, 12,   Bil↓, 2,   Bil∅, 1,   Catalase↑, 1,   GPx↑, 1,   GSH↑, 5,   HDL↓, 2,   HDL↑, 4,   HO-1↑, 1,   Iron↓, 1,   Iron↑, 1,   lipid-P↓, 2,   MDA↓, 4,   MDA↑, 1,   MPOD↑, 2,   NRF2↑, 2,   PCO↓, 1,   ROS↓, 17,   SAM-e↓, 1,   SOD↑, 3,   TAC↑, 6,   TBARS↓, 1,   uricA↓, 1,  

Metal & Cofactor Biology(tgid=2) ⓘ

IronCh↑, 1,  

Mitochondria & Bioenergetics(tgid=3) ⓘ

Insulin↓, 1,   mitResp↑, 1,   mtDam↓, 1,   PGC-1α↑, 1,  

Core Metabolism/Glycolysis(tgid=4) ⓘ

12-HETE↓, 1,   5-HETE↓, 1,   ACLY↓, 1,   AcOH↑, 2,   adiP↑, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   AMPK↑, 1,   Buty↑, 4,   CRM↑, 1,   DHA↑, 2,   Eic↓, 1,   FFA/NEFA↓, 1,   FFA/NEFA↝, 1,   glucose↓, 1,   glucose∅, 1,   KeyT↝, 1,   lactateProd↓, 1,   LDL↓, 11,   lipidLev↓, 1,   NH3↓, 1,   PA↑, 2,   SCFAs↑, 3,   SCFAs∅, 1,   SIRT1↑, 1,   Uridine↑, 1,  

Cell Death(tgid=5) ⓘ

BAX↓, 1,   Casp3↓, 1,   p38↓, 1,  

Kinase & Signal Transduction(tgid=6) ⓘ

CK2↓, 1,   PI3K↓, 1,  

Transcription & Epigenetics(tgid=7) ⓘ

AntiThr↑, 3,   DNMT3A↑, 1,   HDAC3↓, 1,   other?, 3,   other↓, 4,   other↑, 18,   other↝, 20,   other∅, 1,  

DNA Damage & Repair(tgid=10) ⓘ

DNAdam↓, 1,   DNArepair↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12) ⓘ

Choline↑, 1,   Diff↝, 1,   EP2↑, 1,   IGF-1↓, 1,   IGF-1↑, 1,   IGFBP3↓, 1,   NOTCH↓, 1,   Wnt↓, 1,  

Migration(tgid=13) ⓘ

AntiAg↑, 5,   AntiAg∅, 1,   MMP9↓, 1,   TGF-β↑, 1,  

Angiogenesis & Vasculature(tgid=14) ⓘ

NO↓, 1,   TXA2↓, 1,   VCAM-1↓, 1,   VEGF↑, 1,  

Barriers & Transport(tgid=15) ⓘ

BBB↑, 1,   IBI↑, 1,  

Immune & Inflammatory Signaling(tgid=16) ⓘ

CD14↑, 1,   COX1↓, 1,   Eos↓, 1,   IFN-γ↓, 1,   IFN-γ↑, 5,   IgA↑, 1,   IgE↓, 1,   IL1↓, 1,   IL10↓, 2,   IL10↑, 1,   IL10∅, 1,   IL12↓, 1,   IL17∅, 1,   IL1β↓, 6,   IL4↑, 1,   IL4∅, 1,   IL6↓, 12,   IL8↓, 1,   Imm↑, 7,   Inflam↓, 26,   IP-10/CXCL-10↓, 1,   MCP1/CCL2↓, 1,   MCP1/CCL2↝, 1,   MIP‑1α/CCL3?, 1,   NF-kB↓, 1,   NK cell↑, 5,   PGE2↓, 2,   PGE2∅, 1,   PSA↓, 1,   TNF-α↓, 9,   TNF-α↑, 3,   VitD↑, 1,  

Synaptic & Neurotransmission(tgid=18) ⓘ

5-AR↓, 1,   5HT↑, 3,   Ach↑, 2,   AChE↓, 5,   BDNF↑, 8,   BDNF∅, 1,   proBDNF↑, 1,   BrainVol↑, 1,   BrainVol↝, 1,   BrainVol∅, 3,   GABA↑, 1,   NGF↑, 2,  

Protein Aggregation(tgid=19) ⓘ

APOE4↑, 1,   Aβ↓, 10,   Aβ∅, 1,   BACE/β-secretase↓, 1,   tau↓, 3,   p‑tau↓, 1,  

Hormonal & Nuclear Receptors(tgid=20) ⓘ

2/16-OHE1↑, 1,   cortisol↓, 1,   END↑, 1,   ENL↑, 1,  

Drug Metabolism & Resistance(tgid=21) ⓘ

BioAv↓, 5,   BioAv↑, 22,   BioAv↝, 14,   Dose?, 20,   Dose↓, 1,   Dose↑, 8,   Dose↝, 143,   eff↓, 2,   eff↑, 20,   eff↝, 8,   eff∅, 1,   Half-Life↓, 2,   Half-Life↑, 2,   Half-Life↝, 20,   P450↓, 1,   Synergy↑, 6,  

Clinical Biomarkers(tgid=22) ⓘ

ADC↓, 1,   ALAT↓, 6,   ALAT↑, 1,   ALAT∅, 2,   ALB↑, 3,   ALP↓, 1,   AST↓, 4,   AST↑, 1,   AST∅, 2,   Bil↓, 2,   Bil∅, 1,   BloodF↑, 4,   BMD↑, 1,   BP↓, 12,   BP∅, 2,   Calcium↑, 1,   CCr / CrCl↓, 1,   CCr / CrCl∅, 1,   creat∅, 1,   CRP↓, 5,   FEV1↑, 2,   Hcy/homoC↓, 13,   Hcy/homoC↝, 1,   HemoG↑, 2,   HRV↑, 1,   hs-CRP↓, 2,   IL6↓, 12,   IRes↓, 1,   KeyT↝, 1,   LDH↓, 3,   NLR↓, 1,   PC∅, 1,   PEF↑, 1,   PSA↓, 1,   rHR↓, 1,   TC↓, 3,   TG/TAG↓, 3,   TMAO∅, 1,   UFR?, 1,   UFR↑, 1,   UR↓, 1,   Verbal↑, 2,   VitD↑, 1,   WBC∅, 1,  

Functional Outcomes(tgid=23) ⓘ

AntiAge↑, 1,   antiAll↑, 2,   AntiCan↑, 2,   antiD↑, 3,   AntiDiabetic↑, 2,   AntiTum↑, 3,   ANXi↓, 5,   BDI↓, 1,   BowelM↑, 1,   cardioP↑, 6,   chemoP↑, 3,   cognitive?, 1,   cognitive↓, 1,   cognitive↑, 78,   cognitive↝, 2,   cognitive∅, 12,   fatigue↓, 2,   GFR↓, 1,   GFR∅, 1,   hepatoP↑, 8,   IPSS↓, 1,   IPSS↝, 1,   Learn↑, 1,   memory↑, 26,   memory∅, 1,   Mood↑, 10,   motorD↑, 13,   MusCon↓, 1,   neuroP↑, 13,   NMSS↓, 1,   Obesity↓, 3,   OS↑, 1,   Pain↓, 12,   QoL?, 1,   QoL↑, 13,   RenoP↑, 3,   Risk↓, 6,   Risk↑, 2,   Risk↝, 1,   RT↓, 2,   Sleep↑, 12,   Strength↑, 4,   Stress↓, 6,   Tinn↓, 1,   toxicity↓, 40,   toxicity↑, 1,   toxicity↝, 4,   toxicity∅, 7,   UPDRS↓, 1,   UPDRSIII∅, 1,   Weight↓, 1,   Wound Healing↑, 1,  

Infection & Microbiome(tgid=24) ⓘ

AntiBio↑, 2,   AntiFungal↑, 2,   AntiViral↑, 4,   Bacteria↓, 2,   GutMicro↑, 10,   GutMicro∅, 1,   Inf↓, 1,  

Ingredients & Constituents(tgid=25) ⓘ

Ingr↝, 8,  
Total Targets: 266

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:%  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page